Important Notice

Vantage Global Prime LLP (“Vantage Markets”) is authorised and regulated by the Financial Conduct Authority (FRN: 590299).

The IP address you have accessed our site from suggests you are domiciled in Singapore. Vantage Markets does not actively solicit, market or promote its products or services to persons in Singapore.

If you are accessing our site from Singapore then, by clicking “Confirm and Enter Website”, you confirm that:

you are accessing this Website entirely on your own initiative;

your access is not the result of any direct solicitation or targeted marketing, or promotional activity by Vantage Markets nor from such activity of any person or company acting as an agent of Vantage Markets; and

you are responsible for determining whether accessing this Website and any products or services made available through it is permitted under the laws and regulations applicable to you.

Access to this Website does not constitute an offer, invitation or solicitation by Vantage Markets to provide any product or service in any jurisdiction where such offer, invitation or solicitation would be unlawful.

Confirm and Enter Website Exit Website

Access Restricted

Your access to this website is restricted.

Our website and services are not available to, and are not intended for, individuals who are citizens or residents of the United States, or entities incorporated in or conducting business within the United States.

If this does not apply to you and you believe you have received this message in error, please contact us at support@vantagemarkets.co.uk for further assistance.

If you fall into any of the above categories, please exit the site.

Important Information

Thank you for visiting the Vantage Markets website. Please note that this website is intended for individuals residing in jurisdictions where accessing it is permitted by Vantage and its affiliated entities do not operate in your home jurisdiction.

By clicking 'I CONFIRM MY INTENTION TO PROCEED AND ENTER THIS WEBSITE', you confirm that you are entering this website solely based on your initiative and not as a result of any specific marketing outreach. You wish to obtain information from this website based on reverse solicitation principles, in accordance with the applicable laws of your home jurisdiction.

I CONFIRM MY INTENTION TO PROCEED AND ENTER THIS WEBSITE
SEARCH
  • All
    Trading
    Platforms
    Academy
    Analysis
    Promotions
    About
  • Search query too short. Please enter a full word or phrase.
  • Search
Keywords
SEARCH
  • All
    Trading
    Platforms
    Academy
    Analysis
    Promotions
    About
  • Search query too short. Please enter a full word or phrase.
  • Search
Keywords
  • youtube
  • facebook
  • instagram
  • twitter
  • linkedin

Why the Dow Jones Rose as Healthcare Lifted Blue Chips – DJ30 Analysis

Vantage Editorial Team

Vantage Editorial Team >

Vantage Editorial Team

Vantage Editorial Team >

View Profile

Vantage is a global, multi-asset broker with a team of in-house writers and market analysts who produce educational and insightful trading content for traders of all levels.

Vantage Updated Thu, 2026 October 22 06:33

Key Takeaways

  • The Dow Jones Industrial Average closed 529.85 points, or 1.02%, higher at 52,495.88 on 20 October, while the S&P 500 added 0.28% and the Nasdaq Composite slipped 0.02%.1
  • 3M, UnitedHealth, Merck, Johnson & Johnson, and Amgen posted the largest gains among Dow members, and healthcare hit a record high as the top S&P 500 sector.2,4

The Dow Jones Industrial Average gained 1.02% to 52,495.88 on Tuesday, 20 October, a day the Nasdaq Composite finished 0.02% lower.1 Hours later, the script flipped: Nasdaq 100 futures climbed 1% while Dow futures barely twitched.5 As of 09:54 (GMT+8) today, Dow Jones index levels on the Vantage DJ30 feed stood at 52,526.39; the 52-week range runs from 45,057.28 to 54,744.33.6

Blue chips by day and tech by night is not the tidy narrative anyone ordered. For anyone tracking the Dow Jones today from Asia, that split is the story.

So why did the Dow outrun Wall Street by a full percentage point? This piece digs into how a few high-priced shares moved a price-weighted index, what the Dow Jones chart shows after the jump, and what that means into the Federal Reserve’s 28 October decision.

Why Did the Dow Jones Rise on 20 October?

The Dow Jones rose 1.02% to 52,495.88 on 20 October as UnitedHealth, 3M, and other high-priced healthcare and industrial members rallied, and price weighting gave those shares extra pull. The S&P 500 gained just 0.28%, while the Nasdaq Composite slipped 0.02% as technology stocks lagged.

Table 1: How the Three Major US Indices Compared on 20 October 2026

IndexHow It Is WeightedClose on 20 OctoberFutures by 09:25 (GMT+8), 21 October
Dow Jones Industrial AverageShare price+1.02% to 52,495.88Largely unchanged
S&P 500Company market value+0.28% to 7,712.57+0.3%
Nasdaq CompositeCompany market value-0.02% to 26,424.82Nasdaq 100 futures +1%

Table 1: Closing data from The Motley Fool and futures data from Investing.com, as of 21:25 ET on 20 October 2026 (09:25 GMT+8, 21 October).1,5

Healthcare Stocks Carried the Blue Chips

Dow Jones news on 20 October belonged to healthcare. The sector led all 11 S&P 500 groups to a record high, Reuters reported, with Dow members UnitedHealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), and Amgen (NASDAQ:AMGN) among the contributors.2

UnitedHealth rose 3.47% to $420.99, a week after lifting its full-year adjusted earnings guidance to at least $20.50 per share.4,8 3M (NYSE:MMM) topped all 30 members with a 5.38% gain after raising guidance and expanding a data-centre deal with Amazon.2,4

Robert Pavlik, senior portfolio manager at Dakota Wealth, pointed to “strength in some high-value stocks and the Dow” as the lift for the wider market.9 Jim Baird, chief investment officer at Plante Moran Financial Advisors, described “a bit of a rotation into other areas of the market,” with investors still wary of the AI trade.10

Cheaper crude helped too, as oil eased on hopes of diplomatic progress in the Middle East and the 10-year Treasury yield slipped to 5.11%.1

That tells us which shares rose. It does not tell us why a 0.28% day for the S&P 500 became a 1.02% day for the Dow.

Price Weighting Explains the 1% Gap

Here is the quirk. The Dow Jones share index is price-weighted, so each Dow Jones stock price, not the size of the company behind it, decides how many points a move is worth. FXStreet puts the divisor at 0.152, meaning a $1 move in any member shifts the index by about 6.58 points.3 Vantage has not independently verified the divisor.

In that arithmetic, a $420 share talks louder than a $170 one. With UnitedHealth near $421 and 3M near $171,4 the same percentage move in UnitedHealth was worth roughly 2.5 times the points, and FXStreet’s tally had it adding about three times as many as 3M.3

The Dow gained 1.02% on a day the S&P 500 gained 0.28%, and much of that gap sits in a handful of high-priced shares.

The arithmetic is unglamorous, but it explains why the Dow can look braver than the market it represents. For DJ30 watchers, that means concentration: one high-priced member’s earnings can move the index more than a broad sector shift.

Concentration explains the size of the move. The Dow Jones chart shows what happened to momentum once it was done.

Dow Jones Chart: Momentum Cools Near the High

DJ30_2026-10-21_09-54-47
Figure 1: DJ30 H1 “Dow Jones Chart With 50- and 200-Period Moving Averages and 14-Period RSI, 13 to 21 October 2026” (TradingView, https://www.tradingview.com/) Accessed on 21 October 2026. Data indicative, for informational purposes only.

Most of the move landed in one hourly candle on 20 October, lifting Vantage DJ30 from around 52,000 to a session high near 52,750 (Figure 1). As of 09:54 (GMT+8) on 21 October 2026, price sat at 52,526.39, above both the 50-period (52,217.30) and 200-period (51,886.19) moving averages.

Momentum is where the chart gets quieter. On the TradingView setup used for this analysis, the 14-period Relative Strength Index (RSI) pushed above 70 on the breakout, then eased to 58.20, below its own average of 60.60. Price has held most of the gain while RSI has handed back roughly half of its jump; the indicator has stopped shouting and started talking.

Table 2: Dow Jones Levels Traders Are Watching, as of 09:54 (GMT+8) on 21 October 2026

LevelPrice AreaWhat It Marks
Level 1 ResistanceNear 52,75020 October session high (H1)
Last Price52,526.39Data cut-off reading
Level 1 Support52,217.3050-period moving average (H1)
Level 2 SupportNear 52,000Base of the 20 October breakout candle
Level 3 Support51,886.19200-period moving average (H1), near the 16 to 19 October swing lows
Level 4 SupportNear 51,40014 to 15 October low

Table 2: Levels read from the Vantage DJ30 H1 chart on TradingView, as of 09:54 (GMT+8) on 21 October 2026. Reference levels only, not trade signals.

The chart was cut at 09:54 (GMT+8). By then, the futures market had already moved the spotlight.

Dow Jones Futures Today Leaned Toward Tech

Watching Dow Jones futures live overnight was a lesson in sitting still. After the bell, SpaceX (NASDAQ:SPCX) rose more than 8% and Netflix (NASDAQ:NFLX) fell 6% on results, and neither is a Dow member.5

Across Dow Jones stock markets, futures told a different story: by 09:25 (GMT+8), Nasdaq 100 futures were up 1% while Dow futures sat largely unchanged at 52,699.00.5

So what tests Tuesday’s leadership next?

Four Dow Earnings Reports Before the Fed

Four Dow members report within three days, and the Fed decides a week from today.3 All times are GMT+8.

  • IBM, 22 October, 05:00: IBM (NYSE:IBM), one of Tuesday’s biggest point contributors, reports after the US close, at an hour better suited to coffee than to conference calls.3
  • Honeywell and Procter & Gamble, 22 October, 20:30: Honeywell International (NASDAQ:HON) and Procter & Gamble (NYSE:PG) hold calls after reporting before the US open.3
  • US Jobless Claims, 22 October, 20:30: Initial claims are forecast at 200,000 after 199,000.3
  • American Express, 23 October, Before the US Open: American Express (NYSE:AXP) rounds out four Dow reports in three days.3
  • Fed Decision, 29 October, 02:00: CME FedWatch priced a 17.2% chance of a quarter-point hike, as reported by FX Empire.7

Our read weakens if the S&P 500 and Nasdaq match further Dow gains, a sign of broader participation, or if RSI reclaims its average with price above 52,217.30.

A few questions come up every time the Dow and the Nasdaq split like this.

Dow Jones Today: Quick Answers

What Is Driving the Dow Jones Stock Market Today?

Healthcare and 3M’s results lifted several high-priced Dow members, and price weighting magnified their effect.2,3

Where Is the Dow Jones Index Today Compared With Its High?

As of 09:54 (GMT+8) on 21 October 2026, Vantage DJ30 traded at 52,526.39, about 4.05% below the 54,744.33 52-week high.6 The Dow Jones live price on a futures screen can differ, as futures carry their own pricing.

Does This Analysis Make Stock Market Predictions?

No. It records what moved and the levels traders are watching as of the cut-off. The chart stops at 09:54 (GMT+8), and so do we.

Which brings us back to Tuesday’s split.

Concentrated Gains Raise Gap Risk

Blue chips by day, tech by night: both readings were accurate. Today’s Dow Jones index picture shows a 1.02% gain built largely on a few high-priced names, with momentum cooling while price holds near 52,526.39 as of 09:54 (GMT+8) on 21 October 2026. The four Dow reports and the Fed decision are the scheduled tests of that concentration.

Earnings weeks can move a price-weighted index in sharp, single-stock steps, and results released outside US hours can open the DJ30 at a gap. A Stop Loss order is designed to limit losses to a planned size, but in a gap it can be filled at a worse price than the level set. Some traders review open exposure ahead of releases such as IBM’s on 22 October for that reason.

Leverage works in both directions: at 1:100, a 1% move in the index equals a 100% change in the margin committed, favourable or not. Position size relative to total account equity decides how much of an account one move can affect. Contracts for Difference (CFDs) are complex instruments and carry a high risk of losing money rapidly due to leverage.

Related Reading

RISK WARNING: CFDs are complex financial instruments and carry a high risk of losing money rapidly due to leverage. You should ensure you fully understand the risks involved and carefully consider whether you can afford to take the high risk of losing your money before trading.

Disclaimer: The information is provided for educational purposes only and doesn’t take into account your personal objectives, financial circumstances, or needs. It does not constitute investment advice. We encourage you to seek independent advice if necessary. The information has not been prepared in accordance with legal requirements designed to promote the independence of investment research. No representation or warranty is given as to the accuracy or completeness of any information contained within. This material may contain historical or past performance figures and should not be relied on. Furthermore estimates, forward-looking statements, and forecasts cannot be guaranteed. The information on this site and the products and services offered are not intended for distribution to any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

References

[1] “Stock Market Midday, Oct. 20: Blue Chips Rally, Eli Lilly Gains 5% – The Motley Fool” https://www.fool.com/coverage/stock-market-today/2026/10/20/stock-market-midday-oct-20-blue-chips-rally-eli-lilly-gains-5/ Accessed on 21 October 2026.

[2] “Dow Leads Wall Street Higher, Investors Focus on Healthcare Stocks – Reuters via Kitco” http://www.kitco.com/news/off-the-wire/2026-10-20/dow-leads-wall-street-higher-investors-focus-healthcare-stocks Accessed on 21 October 2026.

[3] “Dow Jones Industrial Average Rises on Earnings, Cheaper Crude Oil – FXStreet” https://www.fxstreet.com/news/dow-jones-industrial-average-rises-on-earnings-cheaper-crude-oil-202610202004 Accessed on 21 October 2026.

[4] “Dow Jones Top Gainers on Oct. 20, 2026: MMM, UNH, MRK Lead Session – Chartmill” https://www.chartmill.com/news/MMM/Chartmill-56466-Dow-Jones-Top-Gainers-on-Oct-20-2026-MMM-UNH-MRK-Lead-Session Accessed on 21 October 2026.

[5] “U.S. Stock Futures Rise as SpaceX Surges on Upbeat Earnings – Investing.com” https://www.investing.com/news/stock-market-news/us-stock-futures-rise-as-spacex-surges-on-upbeat-earnings-4961479 Accessed on 21 October 2026.

[6] “Dow Jones Industrial Average Historical Data – Investing.com” https://ng.investing.com/indices/us-30-historical-data Accessed on 21 October 2026.

[7] “Gold (XAUUSD) Price Forecast: Oil Premium and December Rate Bet Keep Sellers in Control – FX Empire” https://fxempire.com/forecasts/article/gold-xauusd-price-forecast-oil-premium-and-december-rate-bet-keep-sellers-in-control-1639045 Accessed on 21 October 2026.

[8] “UnitedHealth Group Reports Third Quarter 2026 Results – SEC EDGAR” https://www.sec.gov/Archives/edgar/data/0000731766/000073176626000255/earningsrelease3q26unh.htm Accessed on 21 October 2026.

[9] “Wall Street Gains as Healthcare Stocks Rally, Oil Prices Fall – Reuters via The Detroit News” https://www.detroitnews.com/story/business/2026/10/20/wall-street-gains-as-healthcare-stocks-rally-oil-prices-fall/92345674007/ Accessed on 21 October 2026.

[10] “Dow Leads Wall Street Higher as Investors Focus on Healthcare Stocks – Reuters via Free Malaysia Today” https://www.freemalaysiatoday.com/category/business/2026/10/21/dow-outperforms-as-wall-street-rises-as-healthcare-stocks-lead-gains Accessed on 21 October 2026.

The information has been prepared as of the date published and is subject to change thereafter. The information is provided for educational purposes only and doesn't take into account your personal objectives, financial circumstances, or needs. It does not constitute investment advice. We encourage you to seek independent advice if necessary. The information has not been prepared in accordance with legal requirements designed to promote the independence of investment research. No representation or warranty is given as to the accuracy or completeness of any information contained within. This material may contain historical or past performance figures and should not be relied on. Furthermore estimates, forward-looking statements, and forecasts cannot be guaranteed. The information on this site and the products and services offered are not intended for distribution to any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.